Randomised clinical trial: prucalopride, a colonic pro‐motility agent, reduces the duration of post‐operative ileus after elective gastrointestinal surgery

Abstract

Prucalopride is a safe and effective treatment to reduce post-operative ileus and systemic inflammation without affecting post-operative complications in patients undergoing elective gastrointestinal surgery. ClinicalTrials.gov: NCT02004652.